GO:1904894 positive regulation of receptor signaling pathway via STAT: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904894 describes any process that activates or increases the frequency, rate or extent of receptor signaling pathway via STAT, a central cytokine-to-nucleus communication route.
• The pathway converts extracellular cytokine signals into transcriptional programs through JAK-mediated phosphorylation of STAT proteins, followed by STAT dimerization and nuclear translocation.
• Positive regulation is achieved by ligand availability, receptor complex assembly, JAK activity, and negative regulators such as SOCS proteins and phosphatases.
• TRAF2 and TRAF5 act as context-dependent regulators that can limit or enhance IL-6 and IL-27 receptor signaling in CD4+ T cells.
• Dysregulated STAT signaling is linked to inflammatory diseases including rheumatoid arthritis, Behçet's uveitis, and cytokine-driven autoimmunity.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of positive regulators within this pathway.
Description
GO:1904894, positive regulation of receptor signaling pathway via STAT, is a Gene Ontology biological process term that captures any event which activates or increases the frequency, rate or extent of receptor signaling through Signal Transducer and Activator of Transcription (STAT) proteins. This term sits at the intersection of cytokine biology and transcriptional control, because receptor signaling via STAT is the principal route by which many cytokines, interferons, and growth factors reprogram gene expression. Researchers annotate this term when a perturbation, such as increased ligand, enhanced receptor assembly, or reduced negative feedback, elevates STAT-dependent transcription. The pathway is not a single linear cascade but a modular system in which receptor-associated Janus kinases (JAKs) phosphorylate STAT monomers, allowing them to dimerize, enter the nucleus, and regulate target genes. Positive regulation therefore includes both direct activation steps and relief of inhibition. Because the same module is used by dozens of cytokines, its output is shaped by cell type, receptor composition, and the balance of positive and negative regulators. This makes GO:1904894 a useful annotation for studies of inflammation, immunity, and cytokine-driven disease. In this article we define the term, describe its molecular logic, list key genes, and outline CRISPR-based methods for causal testing.
positive regulation of receptor signaling pathway via STAT At A Glance
| GO ID | GO:1904894 |
|---|---|
| GO term | positive regulation of receptor signaling pathway via STAT |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of receptor signaling pathway via STAT. |
| Synonyms | activation of kinase activated-STAT cascade; activation of kinase-STAT cascade; activation of STAT cascade; activation of STAT signalling pathway; positive regulation of kinase activated-STAT cascade; positive regulation of kinase-STAT cascade; positive regulation of STAT signalling pathway; up regulation of kinase activated-STAT cascade; up-regulation of kinase activated-STAT cascade; upregulation of kinase activated-STAT cascade; up regulation of kinase-STAT cascade; up-regulation of kinase-STAT cascade; upregulation of kinase-STAT cascade; up regulation of STAT cascade; up-regulation of STAT cascade; upregulation of STAT cascade; up regulation of STAT signalling pathway; up-regulation of STAT signalling pathway; upregulation of STAT signalling pathway |
| Major function | Enhances cytokine and growth factor signaling that converges on STAT transcription factors. |
| Biological context | Cytokine signaling modules in inflammatory and immune responses. |
| Key regulators | JAK kinases, STAT proteins, cytokine receptors, SOCS proteins, phosphatases, TRAF2/TRAF5. |
| Disease relevance | Rheumatoid arthritis, Behçet's uveitis, inflammatory CD4+ T cell differentiation, and cytokine-driven autoimmunity. |
What Is GO:1904894?
In our own words, GO:1904894 refers to any biological process that activates or increases the frequency, rate, or extent of a receptor signaling pathway that operates through STAT proteins. It is a positive regulatory term: it does not describe the core STAT cascade itself, but the events that enhance it, such as increased cytokine ligand, receptor activation, JAK activity, or reduced suppression by negative regulators.
Why Is positive regulation of receptor signaling pathway via STAT Important in Cell Biology?
GO:1904894 matters because receptor signaling via STAT is one of the most frequently used communication channels between the extracellular environment and the nucleus, and its positive regulation determines the magnitude and duration of transcriptional responses to cytokines and interferons. When this positive regulation is excessive or poorly restrained, it can drive chronic inflammation and autoimmune pathology, as seen in rheumatoid arthritis and Behçet's uveitis. Conversely, insufficient positive regulation can impair host defense, as illustrated by IFN receptor complex-JAK/STAT signaling in antibacterial immunity. Understanding the positive regulators of this pathway is therefore essential for interpreting cytokine biology, designing experiments, and identifying therapeutic targets.
• Controls the strength of cytokine and interferon responses through JAK-STAT modules.
• Determines transcriptional output of inflammatory cytokines such as IL-6 and IL-27.
• Is a central mechanism in CD4+ T cell differentiation and immune activation.
• Contributes to antibacterial immune regulation via IFN receptor-JAK/STAT-complement signaling.
• Is implicated in rheumatoid arthritis pathogenesis and acupuncture-related network mechanisms.
• Is dysregulated in Behçet's uveitis with aberrant naive CD4+ T cell differentiation.
• Provides a target for negative regulators such as SOCS proteins and phosphatases.
• Can be modulated by TRAF2 and TRAF5 in a context-dependent manner.
• Serves as a readout for cytokine signaling in immunology and inflammation research.
• Enables CRISPR-based causal testing of positive regulators in disease models.
What Happens During positive regulation of receptor signaling pathway via STAT?
Ligand availability and receptor engagement
In simple terms: More cytokine ligand or better receptor engagement means more signal gets started.
Positive regulation begins when extracellular cytokines or interferons bind their cognate receptors, increasing the probability of receptor dimerization or conformational activation. In inflammatory settings, cytokines such as IL-6 and IL-27 engage receptor complexes on CD4+ T cells, and the availability of these ligands directly influences the strength of downstream STAT activation. In teleost immunity, IFN1 binding to the IFN receptor complex initiates JAK/STAT signaling that enhances thrombocyte phagocytosis and antibacterial regulation. Thus, any process that increases ligand concentration, receptor surface expression, or receptor affinity can positively regulate this pathway.
JAK activation and STAT phosphorylation
In simple terms: JAK enzymes tag STAT proteins with phosphate groups so they can pair up and move to the nucleus.
Once receptors are engaged, receptor-associated JAK kinases become activated and phosphorylate STAT monomers on conserved tyrosine residues. This phosphorylation is the committed step that converts latent cytoplasmic STATs into activated signaling molecules. Positive regulation of the pathway can occur through increased JAK activity, enhanced coupling between receptor and JAK, or reduced dephosphorylation by phosphatases. The ROCK-JAK relationship illustrates that kinase networks can intersect with JAK regulation, adding another layer of positive or negative control.
STAT dimerization and nuclear translocation
In simple terms: Phosphorylated STATs pair up and travel into the nucleus to switch genes on.
Phosphorylated STAT monomers dimerize through reciprocal phosphotyrosine-SH2 domain interactions and translocate to the nucleus, where they bind DNA and regulate target gene transcription. Positive regulation of receptor signaling via STAT therefore includes processes that stabilize dimers, promote nuclear import, or retain STATs in the nucleus. Because STAT dimers directly control gene expression, the magnitude of positive regulation shapes the transcriptional response to cytokines.
Negative feedback and its relief
In simple terms: Brakes on the pathway can be released, which counts as positive regulation.
Suppressor of cytokine signaling (SOCS) proteins and phosphatases normally restrain JAK-STAT signaling. Any process that reduces the expression or activity of these negative regulators effectively increases pathway output and is therefore a form of positive regulation. TRAF2 and TRAF5 provide additional context-dependent control of IL-6 and IL-27 receptor signaling in CD4+ T cells, and their loss or gain can shift the balance of STAT activation. This layer of regulation is critical because it determines whether a cytokine signal is transient or sustained.
Cell-type and context specificity
In simple terms: The same pathway behaves differently depending on the cell and the cytokine.
Positive regulation of receptor signaling via STAT is highly context-dependent. In CD4+ T cells, IL-6 and IL-27 receptor signaling is modulated by TRAF2 and TRAF5 during inflammatory differentiation. In Behçet's uveitis, single-cell transcriptomic profiling revealed aberrant CD4+ naive T cell differentiation driving immune activation, implicating STAT-linked cytokine signaling in disease. In rheumatoid arthritis, network topology and machine learning analyses have highlighted cytokine signaling modules as potential therapeutic nodes. These examples show that positive regulation must be interpreted within a specific cellular and disease context.
Key Genes Involved in GO:1904894 positive regulation of receptor signaling pathway via STAT
The following genes and proteins are central to positive regulation of receptor signaling pathway via STAT, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STAT1 | Transcription factor activated by IFN and cytokine receptor signaling | Mediates IFN-γ/STAT1 signaling in Th1 cells |
| STAT3 | Transcription factor downstream of IL-6 family cytokines | Central to IL-6 receptor signaling in CD4+ T cells |
| JAK1 | Janus kinase that phosphorylates STAT proteins | Core kinase in cytokine receptor signaling modules |
| JAK2 | Janus kinase associated with cytokine receptors | Mediates JAK-STAT signaling in multiple cytokine pathways |
| JAK3 | Janus kinase important in lymphoid cells | Participates in cytokine signaling modules |
| TYK2 | Janus kinase involved in IFN and IL-12 signaling | Contributes to STAT-dependent cytokine responses |
| IL6R | IL-6 receptor subunit | Initiates IL-6 signaling in inflammatory T cells |
| IL27RA | IL-27 receptor subunit | Limits or modulates IL-27 signaling in CD4+ T cells |
| TRAF2 | Adaptor protein regulating cytokine receptor signaling | Regulates IL-6 receptor signaling during T cell differentiation |
| TRAF5 | Adaptor protein limiting IL-27 receptor signaling | Restrains IL-27 receptor signaling in CD4+ T cells |
| SOCS1 | Negative regulator of JAK-STAT signaling | Provides feedback control of cytokine signaling |
| SOCS3 | Negative regulator of JAK-STAT signaling | Restrains IL-6 family cytokine signaling |
| IFNAR1 | Type I IFN receptor subunit | Mediates IFN1-JAK/STAT signaling in teleost immunity |
| IFNAR2 | Type I IFN receptor subunit | Part of the IFN receptor complex activating JAK/STAT |
| Aiolos | Transcription factor promoting CXCR3 expression | Acts via positive regulation of IFN-γ/STAT1 signaling |
| CXCR3 | Chemokine receptor induced by STAT1 signaling | Readout of Aiolos-driven STAT1 positive regulation |
| ROCK | Kinase that intersects with JAK regulation | Modulates JAK-STAT signaling through kinase crosstalk |
How Is positive regulation of receptor signaling pathway via STAT Regulated?
Positive regulation of receptor signaling pathway via STAT is itself controlled by multiple feedback and crosstalk mechanisms. SOCS proteins and phosphatases provide negative feedback that limits the duration and intensity of STAT activation, so relief of this inhibition is a form of positive regulation. TRAF2 and TRAF5 act as context-dependent modulators of IL-6 and IL-27 receptor signaling in CD4+ T cells, demonstrating that adaptor proteins can tune STAT output. Kinase crosstalk, such as the relationship between ROCK and JAKs, adds another layer of regulation that can either enhance or restrain signaling depending on context. In disease states, aberrant positive regulation can become self-sustaining, as suggested by single-cell studies of Behçet's uveitis and network analyses of rheumatoid arthritis.
positive regulation of receptor signaling pathway via STAT and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAT1 | Th1 cell differentiation and IFN-γ signaling | STAT1 knockout or point-mutation T cell lines |
| STAT3 | IL-6-driven inflammatory T cell differentiation | STAT3 knockout CD4+ T cells |
| TRAF5 | IL-27 receptor signaling in CD4+ T cells | TRAF5 knockout or overexpression T cells |
| IFNAR1 | Antibacterial immunity via IFN-JAK/STAT | IFNAR1 knockout teleost or cell model |
| TRAF2 | IL-6 receptor signaling in inflammatory T cells | TRAF2 knockout or knock-in T cells |
Rheumatoid arthritis and inflammatory joint disease
Rheumatoid arthritis is a chronic inflammatory disease in which cytokine signaling modules, including JAK-STAT pathways, contribute to synovial inflammation and immune cell activation. Network topology and machine learning analyses have identified cytokine-related mechanisms as potential therapeutic targets, and acupuncture treatment has been studied for its effects on these networks. Positive regulation of receptor signaling via STAT is therefore relevant to understanding how inflammatory signals are amplified in rheumatoid arthritis.
Behçet's uveitis and T cell-driven autoimmunity
Single-cell transcriptomic profiling in Behçet's uveitis revealed aberrant CD4+ naive T cell differentiation driving immune activation. Because STAT-dependent cytokine signaling is a key driver of T cell differentiation, dysregulated positive regulation of this pathway may contribute to the immune activation observed in this disease. This positions GO:1904894 as a relevant annotation for studies of uveitis and related autoimmune conditions.
Inflammatory CD4+ T cell differentiation
IL-6 and IL-27 receptor signaling regulate the differentiation of inflammatory CD4+ T cells, and TRAF2 and TRAF5 modulate these pathways. Positive regulation of receptor signaling via STAT is therefore central to the balance between effector and regulatory T cell programs. Aiolos promotes CXCR3 expression on Th1 cells via positive regulation of IFN-γ/STAT1 signaling, illustrating how STAT1-dependent transcription shapes T cell phenotype.
Antibacterial immunity and IFN receptor signaling
In teleost models, IFN1 enhances thrombocyte phagocytosis through the IFN receptor complex-JAK/STAT-complement C3.3-CR1 pathway, facilitating antibacterial immune regulation. This demonstrates that positive regulation of receptor signaling via STAT is not limited to mammals and is conserved in immune defense. The pathway connects cytokine receptor activation to complement-mediated phagocytosis, highlighting its broad functional reach.
From positive regulation of receptor signaling pathway via STAT-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce STAT activation? | CRISPR knockout cell line |
| Does a specific phosphosite on STAT control dimerization? | Point-mutation knock-in |
| Does a disease-associated variant alter STAT signaling? | Knock-in of the variant allele |
| Where does a regulator localize during signaling? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a positive regulator enhance STAT output? | Overexpression cell model |
| Which genes modify the pathway in a genome-wide screen? | CRISPR library screening |
How to Study the positive regulation of receptor signaling pathway via STAT Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional output of STAT target genes | Pathway activation profiling |
| Single-cell RNA-seq | Cell-type-specific pathway activity | Behçet's uveitis immune activation |
| Phospho-STAT immunoblot | STAT phosphorylation status | Cytokine stimulation assays |
| Flow cytometry | Phospho-STAT and surface markers | T cell differentiation studies |
| CRISPR knockout | Loss-of-function effect on pathway | Causal gene testing |
| CRISPR point mutation | Effect of specific residues | Phosphosite dissection |
| CRISPR knock-in | Variant or tag function | Disease variant modeling |
| CRISPR library screening | Genome-wide modifiers of pathway | Positive regulator discovery |
Transcriptomic profiling of STAT target genes
RNA sequencing can measure the expression of STAT target genes after cytokine stimulation, providing a readout of positive regulation of receptor signaling via STAT. Single-cell transcriptomic profiling has been used to reveal aberrant CD4+ naive T cell differentiation in Behçet's uveitis, demonstrating how this method can link pathway activity to disease. Network topology and machine learning analyses of transcriptomic data can further identify cytokine signaling modules in rheumatoid arthritis.
Phospho-STAT immunoblotting and flow cytometry
Phosphorylation of STAT proteins is the key activation event in this pathway, and phospho-specific antibodies can quantify it by immunoblotting or flow cytometry. These methods are widely used to assess whether a perturbation increases or decreases STAT activation. In T cell studies, phospho-STAT measurement helps define how TRAF2 and TRAF5 modulate IL-6 and IL-27 receptor signaling.
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes implicated in positive regulation of receptor signaling via STAT. For example, knocking out TRAF5 can test its role as a limiter of IL-27 receptor signaling in CD4+ T cells. Point mutations can dissect phosphosite function, while tagged knock-ins enable localization studies.
Functional immune assays
Functional assays such as phagocytosis, cytokine production, and T cell differentiation can connect STAT pathway activity to immune outcomes. In teleost models, IFN1-enhanced thrombocyte phagocytosis through JAK/STAT-complement signaling provides a functional readout of pathway activation. In CD4+ T cell studies, differentiation assays link IL-6 and IL-27 receptor signaling to inflammatory phenotypes.
How CRISPR Can Be Used to Study GO:1904894 positive regulation of receptor signaling pathway via STAT
Knockout
CRISPR knockout of candidate genes is used to test whether they are required for positive regulation of receptor signaling via STAT. For example, knocking out TRAF5 can reveal its role in limiting IL-27 receptor signaling in CD4+ T cells. Knockout of STAT3 or STAT1 can abolish specific cytokine responses, providing a baseline for pathway dependence.
Point Mutation
Point mutations can be introduced to dissect the function of specific residues, such as STAT phosphorylation sites or receptor tyrosine motifs, without removing the entire protein. This approach is valuable for distinguishing activating from scaffolding functions in the pathway. Point-mutation models also help test whether a disease-associated variant alters STAT signaling.
Knock-in
Knock-in models allow precise replacement of a gene with a variant or tagged version. Tagged knock-ins enable visualization of protein localization during STAT signaling, while disease-variant knock-ins can test pathogenicity. Knock-in of reporter cassettes downstream of STAT target genes can provide a sensitive readout of pathway activity.
Overexpression
Overexpression of positive regulators can enhance receptor signaling via STAT and is useful for gain-of-function studies. Overexpressing SOCS proteins, by contrast, can suppress the pathway and serve as a negative control. Overexpression models are particularly helpful when the endogenous protein is expressed at low levels.
How EDITGENE Supports positive regulation of receptor signaling pathway via STAT Research
Researchers studying positive regulation of receptor signaling pathway via STAT-related genes often need to determine whether a candidate gene is causally involved in pathway activation, whether a specific residue or variant alters signaling, and how the pathway behaves in a disease-relevant cell type. Addressing these questions requires reliable genetic models that can be engineered with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of receptor signaling pathway via STAT research.
Frequently Asked Questions About positive regulation of receptor signaling pathway via STAT
What is GO:1904894?
GO:1904894 is the Gene Ontology term for positive regulation of receptor signaling pathway via STAT, meaning any process that activates or increases the frequency, rate or extent of receptor signaling through STAT proteins.
What genes are involved in positive regulation of receptor signaling pathway via STAT?
Key genes include STAT1, STAT3, JAK1, JAK2, JAK3, TYK2, IL6R, IL27RA, TRAF2, TRAF5, SOCS1, SOCS3, IFNAR1, IFNAR2, and Aiolos.
How is receptor signaling via STAT positively regulated?
Positive regulation occurs through increased ligand availability, receptor engagement, JAK activation, STAT phosphorylation, dimerization, nuclear translocation, and relief of negative feedback by SOCS proteins or phosphatases.
What diseases are linked to STAT signaling dysregulation?
Dysregulated STAT signaling has been linked to rheumatoid arthritis, Behçet's uveitis, inflammatory CD4+ T cell differentiation, and impaired antibacterial immunity.
What is the role of TRAF5 in IL-27 receptor signaling?
TRAF5 limits IL-27 receptor signaling in CD4+ T lymphocytes, acting as a context-dependent modulator of STAT activation.
How does Aiolos regulate STAT1 signaling?
Aiolos promotes CXCR3 expression on Th1 cells via positive regulation of IFN-γ/STAT1 signaling.
Can CRISPR be used to study GO:1904894?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of genes in positive regulation of receptor signaling via STAT.
What methods measure STAT pathway activation?
Phospho-STAT immunoblotting, flow cytometry, RNA-seq, single-cell RNA-seq, and functional immune assays are commonly used to measure STAT pathway activation.
What is the role of SOCS proteins in this pathway?
SOCS proteins are negative regulators of JAK-STAT signaling, and their reduction or inhibition can positively regulate the pathway.
Why is GO:1904894 important for immunology research?
It defines the processes that amplify cytokine and interferon signaling through STAT proteins, which are central to immune cell differentiation, inflammation, and host defense.
Conclusion
GO:1904894, positive regulation of receptor signaling pathway via STAT, provides a precise ontology framework for studying how cytokine and interferon signals are amplified through JAK-STAT modules. Its positive regulators include ligand availability, receptor engagement, JAK activity, and relief of SOCS-mediated feedback, while adaptor proteins such as TRAF2 and TRAF5 fine-tune pathway output in CD4+ T cells. Dysregulation of this pathway is implicated in rheumatoid arthritis, Behçet's uveitis, and inflammatory T cell differentiation, making it a compelling target for functional genomics. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with transcriptomic and phospho-STAT readouts, offer robust tools for causal dissection of this pathway. Researchers can leverage these approaches to identify new positive regulators and therapeutic opportunities in cytokine-driven disease.
References
- 1. Li F et al.. 2025. Potential mechanisms of acupuncture treatment for rheumatoid arthritis: a study based on network topology and machine learning.. Chin Med 20(1):164 PMID: 41053877
- 2. Leonard MR et al.. 2024. Aiolos promotes CXCR3 expression on Th1 cells via positive regulation of IFN-γ/STAT1 signaling.. JCI Insight 10(1) PMID: 39560988
- 3. Peelman F et al.. 2013. ROCKing the JAKs.. JAKSTAT 2(3):e24074 PMID: 24069551
- 4. Nagashima H et al.. 2018. Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4(+) T Cells.. Front Immunol 9:1986 PMID: 30214449
- 5. Zhang L et al.. 2025. Single-cell transcriptomic profiling reveals aberrant CD4⁺ naive T cell differentiation driving immune activation in Behçet's uveitis.. J Transl Med 24(1):32 PMID: 41331613
- 6. Zhu W et al.. 2023. IFN1 Enhances Thrombocyte Phagocytosis through IFN Receptor Complex-JAK/STAT-Complement C3.3-CR1 Pathway and Facilitates Antibacterial Immune Regulation in Teleost.. J Immunol 210(8):1043-1058 PMID: 36883974
- 7. O'Shea JJ et al.. 2008. Cytokine signaling modules in inflammatory responses.. Immunity 28(4):477-87 PMID: 18400190
- 8. Kawahara E et al.. 2022. TNF Receptor-Associated Factor 5 Limits IL-27 Receptor Signaling in CD4(+) T Lymphocytes.. J Immunol 208(3):642-650 PMID: 34996840
